Andre L Moreira Selected Research

Carcinoma (Carcinomatosis)

1/2023	Correlation of Programmed Death-Ligand 1 Expression With Lung Adenocarcinoma Histologic and Molecular Subgroups in Primary and Metastatic Sites.
12/2016	Lung Carcinoma Predictive Biomarker Testing by Immunoperoxidase Stains in Cytology and Small Biopsy Specimens: Advantages and Limitations.
9/2013	Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma.
6/2010	Progenitor stem cell marker expression by pulmonary carcinomas.
2/2008	Cytologic findings after fertility-sparing radical trachelectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andre L Moreira Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 11/2007
16	Lung Neoplasms (Lung Cancer) 02/2024 - 11/2012
15	Adenocarcinoma 02/2024 - 06/2010
15	Adenocarcinoma of Lung 01/2024 - 11/2010
7	Inflammation (Inflammations) 01/2024 - 04/2002
7	Infections 01/2022 - 04/2002
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 03/2011
6	Thymoma (Thymic Carcinoma) 01/2024 - 03/2014
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2024 - 06/2010
5	Carcinoma (Carcinomatosis) 01/2023 - 02/2008
4	COVID-19 01/2022 - 12/2020
4	Granuloma 12/2003 - 04/2002
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 04/2024 - 08/2014
2	Carcinogenesis 09/2023 - 02/2015
2	Aortic Valve Stenosis (Aortic Stenosis) 06/2023 - 01/2023
2	Fibrosis (Cirrhosis) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 12/2014 - 08/2012
2	Squamous Cell Carcinoma of Head and Neck 08/2012 - 04/2012
2	Leukocytosis (Pleocytosis) 04/2006 - 07/2005
2	Visceral Leishmaniasis (Kala Azar) 08/2003 - 11/2002
1	Mediastinal Fibrosis 01/2023
1	Amyloid Plaque 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2023
1	Aortic Valve Disease 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Vaccinia 01/2023
1	Pathologic Complete Response 05/2022
1	Thrombosis (Thrombus) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2021
1	Lung Diseases (Lung Disease) 07/2021
1	Malignant Mesothelioma 06/2021
1	Infarction (Infarctions) 01/2021
1	Neoplasms, Cystic, Mucinous, and Serous 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Adenoma (Adenomas) 01/2021
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2020
1	Transthyretin-Related Hereditary Amyloidosis 09/2020
1	Dyspnea (Shortness of Breath) 09/2020
1	Diverticulitis 09/2020
1	Hyperplasia 10/2019

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2012
5	B7-H1 AntigenIBA 01/2023 - 01/2019
5	AntibodiesIBA 01/2023 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 04/2002
3	Amyloid (Amyloid Fibrils)IBA 06/2023 - 09/2020
3	ParaffinIBA 10/2020 - 06/2010
3	Messenger RNA (mRNA)IBA 01/2017 - 11/2002
3	ErbB Receptors (EGF Receptor)IBA 12/2014 - 09/2013
3	Tyrosine Kinase InhibitorsIBA 12/2014 - 01/2012
3	Interferon-gamma (Interferon, gamma)IBA 12/2003 - 04/2002
3	CytokinesIBA 08/2003 - 04/2002
2	xylometazoline (stas)IBA 01/2024 - 01/2022
2	Immune Checkpoint InhibitorsIBA 11/2023 - 04/2015
2	GlutaminaseIBA 11/2023 - 11/2017
2	AntigensIBA 07/2023 - 04/2002
2	SmokeIBA 01/2023 - 10/2019
2	LigandsIBA 01/2022 - 03/2010
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2021 - 12/2020
2	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2021 - 12/2020
2	Formaldehyde (Formol)FDA Link 10/2020 - 01/2019
2	Thyroid Nuclear Factor 1IBA 01/2019 - 04/2018
2	InterleukinsIBA 03/2010 - 08/2003
2	VaccinesIBA 04/2006 - 04/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2003 - 11/2002
2	Interleukin-12 (IL 12)IBA 08/2003 - 11/2002
2	Interleukin-10 ReceptorsIBA 08/2003 - 11/2002
1	sotorasibIBA 02/2024
1	adagrasibIBA 02/2024
1	AutoantibodiesIBA 01/2024
1	Capsules (Microcapsules)IBA 01/2024
1	AntioxidantsIBA 11/2023
1	Hematoxylin (Haematoxylon)IBA 09/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2023
1	Neutralizing AntibodiesIBA 07/2023
1	ApolipoproteinsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Antisense OligonucleotidesIBA 01/2023
1	AfatinibIBA 01/2023
1	SHP099IBA 01/2023
1	CollagenIBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	AsbestosIBA 06/2021
1	Colloids (Colloid)IBA 01/2021
1	Coloring Agents (Dyes)IBA 12/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2020
1	AA amyloidosisIBA 09/2020
1	diphosphoric acid (pyrophosphoric acid)IBA 09/2020
1	CarcinogensIBA 10/2019

Therapy/Procedure

20	Therapeutics 02/2024 - 01/2011
7	Immunotherapy 11/2023 - 11/2002
3	Radiotherapy 01/2018 - 03/2014
3	Drug Therapy (Chemotherapy) 06/2015 - 11/2002
2	Neoadjuvant Therapy 04/2024 - 05/2022
1	Thrombectomy 01/2022
1	Lung Transplantation 07/2021
1	Contraindications 07/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Colectomy 09/2020